RJA
EPC icon

Raymond James & Associates’s Edgewell Personal Care EPC Stock Holding History

Raymond James & Associates’s Portfolio EPC Stock Details EPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$806K Sell
22,167
-788
-3% -$30.4K ﹤0.01% 2819
2024
Q2 		$923K Buy
22,955
+401
+2% +$15.4K ﹤0.01% 2682
2024
Q1 		$871K Buy
+22,554
New +$851K ﹤0.01% 2681
2022
Q2 		– Sell
-10,812
Closed -$396K – 4075
2022
Q1 		$396K Sell
10,812
-37,605
-78% -$1.53M ﹤0.01% 3216
2021
Q4 		$2.21M Buy
48,417
+6,476
+15% +$261K ﹤0.01% 2117
2021
Q3 		$1.52M Buy
41,941
+4,180
+11% +$172K ﹤0.01% 2291
2021
Q2 		$1.66M Sell
37,761
-28,046
-43% -$1.19M ﹤0.01% 2231
2021
Q1 		$2.61M Buy
65,807
+54,122
+463% +$1.87M ﹤0.01% 1838
2020
Q4 		$404K Buy
+11,685
New +$379K ﹤0.01% 2954
2019
Q2 		– Sell
-30,311
Closed -$1.33M – 3676
2019
Q1 		$1.33M Buy
30,311
+2,408
+9% +$100K ﹤0.01% 2028
2018
Q4 		$1.04M Sell
27,903
-2,083
-7% -$90.9K ﹤0.01% 2068
2018
Q3 		$1.39M Buy
29,986
+9,492
+46% +$502K ﹤0.01% 2036
2018
Q2 		$1.03M Buy
20,494
+2,551
+14% +$117K ﹤0.01% 2183
2018
Q1 		$876K Buy
17,943
+8,480
+90% +$457K ﹤0.01% 2227
2017
Q4 		$562K Sell
9,463
-2,718
-22% -$171K ﹤0.01% 2460
2017
Q3 		$887K Sell
12,181
-3,542
-23% -$261K ﹤0.01% 2169
2017
Q2 		$1.2M Buy
15,723
+9,778
+164% +$719K ﹤0.01% 1903
2017
Q1 		$435K Buy
5,945
+2,346
+65% +$179K ﹤0.01% 2471
2016
Q4 		$263K Sell
3,599
-322
-8% -$24.9K ﹤0.01% 2718
2016
Q3 		$312K Buy
3,921
+278
+8% +$22.4K ﹤0.01% 2600
2016
Q2 		$308K Buy
3,643
+76
+2% +$6.14K ﹤0.01% 2400
2016
Q1 		$287K Buy
+3,567
New +$273K ﹤0.01% 2358
2015
Q3 		– Sell
-10,287
Closed -$1.35M – 2298
2015
Q2 		$1.35M Buy
+10,287
New +$1.06M 0.01% 1564
2015
Q1 		– Sell
-228,943
Closed -$21.8M – 2343
2014
Q4 		$21.8M Buy
228,943
+11,209
+5% +$1.03M 0.11% 203
2014
Q3 		$19.9M Buy
217,734
+9,890
+5% +$885K 0.11% 188
2014
Q2 		$18.8M Buy
207,844
+7,932
+4% +$652K 0.12% 193
2014
Q1 		$14.9M Buy
+199,912
New +$14.6M 0.1% 216

Other funds holding EPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Raymond James & Associates's EPC Position: Q3 2024 in Review

Raymond James & Associates reduced its Edgewell Personal Care (EPC) stake by 3.4% in Q3 2024, selling an estimated $30.4K and leaving 22,167 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2819.

Raymond James & Associates first reported a position in EPC in Q1 2014 and has held it in 27 quarters since. The position peaked at $21.8M in Q4 2014. 257 funds tracked by Wall St. Rank hold EPC as of Q3 2024.

  • Raymond James & Associates held 22,167 shares of Edgewell Personal Care worth $806K as of Q3 2024.
  • Raymond James & Associates sold 788 Edgewell Personal Care shares in Q3 2024, an estimated $30.4K.
  • Edgewell Personal Care made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2819 holding.
  • Raymond James & Associates first reported a position in Edgewell Personal Care in Q1 2014 and has held it in 27 quarters since.
  • Raymond James & Associates's Edgewell Personal Care position peaked at $21.8M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Edgewell Personal Care as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.